Immunogenicity 15910

summary
Sample ID
4136
Response
Positive
Tumor Type
Breast cancer
Gene Symbol
CATB
Transcript ID
None
HLA INFO
DRB1*07:01
TCR INFO

CDR3ACVVFGGNNARLMF

TRBVBV28

TRAVAV12-1

CDR3BCASTLQANYGYTF

T cell Tumor cell DRB1*07:01
sequence
Full length protein sequence (339 aa)
MWQLW
1
ASLCC
6
LLVLA
11
NARSR
16
PSFHP
21
LSDEL
26
VNYVN
31
KRNTT
36
WQAGH
41
NFYNV
46
DMSYL
51
KRLCG
56
TFLGG
61
PKPPQ
66
RVMFT
71
EDLKL
76
PASFD
81
AREQW
86
PQCPT
91
IKEIR
96
DQGSC
101
GSCWA
106
FGAVE
111
AISDR
116
ICIHT
121
NAHVS
126
VEVSA
131
EDLLT
136
CCGSM
141
CGDGC
146
NGGYP
151
AEAWN
156
FWTRK
161
GLVSG
166
GLYES
171
HVGCR
176
PYSIP
181
PCEHH
186
VNGSR
191
PPCTG
196
EGDTP
201
KCSKI
206
CEPGY
211
SPTYK
216
QDKHY
221
GYNSY
226
SVSNS
231
EKDIM
236
AEIYK
241
NGPVE
246
GAFSV
251
YSDFL
256
LYKSG
261
VYQHV
266
TGEMM
271
GGHAI
276
RILGW
281
GVENG
286
TPYWL
291
VANSW
296
NTDWG
301
DNGFF
306
KILRG
311
QDHCG
316
IESEV
321
VAGIP
326
RTDQY
331
WEKI
336
Mutation Information
DNA mutation:
None
Peptide Range:
226 ~ 240
Mut AA position:
None (13 in Wild Type peptide)
Alignment
Wild Type:
"GYNSYSVSNSEKDIMAEIYKNGPVE
||||||||||||.||
Mutant:
GYNSYSVSNSEKHIM----------"
reference
clinic trial
Checkpoint Blockade

None

ACT

N

Vaccination

N

Curative Effect

N

experiment
minimal_peptide

Y

Antigen Type

peptide

T-cell Source

TILs

APC Type

APCs

Assay

ELISPOT